Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

3-Hydroxybutyric acid (sodium)

3-Hydroxybutyric acid sodium (β-Hydroxybutyric acid sodium) is a metabolite that is elevated in type I diabetes. 3-Hydroxybutyric acid sodium can modulate the properties of membrane lipids[1].

Product Specifications

CAS Number

[150-83-4]

Product Name Alternative

β-Hydroxybutyric acid (sodium)

UNSPSC

12352211

Hazard Statement

H302

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-sugar/lipid metabolism

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/3-hydroxybutyric-acid-sodium.html

Purity

99.82

Solubility

DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : 25 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

CC(O)CC(O[Na])=O

Molecular Formula

C4H7NaO3

Molecular Weight

126.09

Precautions

H302

References & Citations

[1]Hsu TT, et al. 3-Hydroxybutyric acid interacts with lipid monolayers at concentrations that impair consciousness. Langmuir. 2013 Feb 12;29 (6) :1948-55.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

Human Endogenous Metabolite

Citation 01

BMC Neurol. 2025 Apr 10;25 (1) :153.|Research Square Preprint. 2024 Aug 08.|Acta Pharm Sin B. 2025 Mar;15 (3) :1430-1446.|Biochem Biophys Res Commun. 2024 Jul 25:734:150449.|Cancer Cell. 2024 Oct 14;42 (10) :1729-1746.e8.|Cell Host Microbe. 2024 Dec 12:S1931-3128 (24) 00444-X.|Cell Metab. 2023 Jan 3;35 (1) :200-211.e9.|Cells. 2022 Sep 25;11 (19) :2987.|Free Radic Biol Med. 2025 Oct 23:241:914-932.|J Nanobiotechnology. 2022 Mar 9;20 (1) :120.|J Nutr Biochem. 2023 Aug:118:109335.|J Pathol. 2025 Oct 23.|Mol Cell. 2023 Sep 7;83 (17) :3171-3187.e7.|Nat Commun. 2025 May 7;16 (1) :4224.|Nat Metab. 2025 Jul;7 (7) :1330-1343.|Nat Protoc. 2024 May;19 (5) :1311-1347.|Pharmaceuticals (Basel) . 2025 Feb 6;18 (2) :219.|Redox Biol. 2024 May 16.|Signal Transduct Target Ther. 2024 Dec 30;9 (1) :367.

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

TPD-OSU [O-Succinimidyl-1,3-dimethylpropyleneuronium tetrafluoroborate]
sc-489728 1 g

TPD-OSU [O-Succinimidyl-1,3-dimethylpropyleneuronium tetrafluoroborate]

Sign In for Pricing
View Details
Ddx4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)
K6612807 1.0 µg DNA

Ddx4 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2)

Sign In for Pricing
View Details
Antxrl 3'UTR Luciferase Stable Cell Line
TU101879 1.0 mL

Antxrl 3'UTR Luciferase Stable Cell Line

Sign In for Pricing
View Details
Olfr1402 ORF Vector (Mouse) (pORF)
ORF052311 1.0 µg DNA

Olfr1402 ORF Vector (Mouse) (pORF)

Sign In for Pricing
View Details
Lentiviral human NQO1 shRNA (UAS) - Lentiviral human NQO1 shRNA (UAS) (100)
GTR15099258 1 Vial

Lentiviral human NQO1 shRNA (UAS) - Lentiviral human NQO1 shRNA (UAS) (100)

Sign In for Pricing
View Details
3-Nitro Ropivacaine
018314 50 mg

3-Nitro Ropivacaine

Sign In for Pricing
View Details